Role of mGluR 1 in synaptic plasticity impairment induced by maltol aluminium in rats

Copyright © 2020. Published by Elsevier B.V..

The main symptoms of Alzheimer's disease (AD) is the loss of learning and memory ability, of which biological basis is synaptic plasticity. Aluminium has been found to cause changes in synaptic plasticity, but its molecular mechanism was unclear. In this study, Sprague-Dawley rats were injected with aluminium maltol (Al(mal)3) through the lateral ventricle to establish an AD-like model. Y-maze, electrophysiological measurements, Golgi staining, scanning electron microscopy, quantitative real-time polymerase chain reaction, and western blot techniques were used to investigate regulation of the metabolic glutamate receptor 1 (mGluR1) in synaptic plasticity impairment induced by Al(mal)3. The results showed that Al(mal)3 inhibited the induction and maintenance of long-term potentiation in the hippocampal CA1 region. During this process, the expression of mGluR1 was up-regulated and it inhibited the expression and phosphorylation of the N-methyl-D-aspartic acid receptors (NMDARs). This mainly affected NMDAR1 and NMDAR2B but did not affect protein kinase C expression.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:78

Enthalten in:

Environmental toxicology and pharmacology - 78(2020) vom: 22. Aug., Seite 103406

Sprache:

Englisch

Beteiligte Personen:

Pan, Baolong [VerfasserIn]
Li, Yaqin [VerfasserIn]
Zhang, Jingsi [VerfasserIn]
Zhou, Yue [VerfasserIn]
Li, Liang [VerfasserIn]
Xue, Xingli [VerfasserIn]
Li, Huan [VerfasserIn]
Niu, Qiao [VerfasserIn]

Links:

Volltext

Themen:

23058-19-7
Aluminum maltolate
EC 2.7.11.13
Journal Article
Maltol aluminium
Metabolic glutamate receptor 1
Metabotropic glutamate receptor type 1
N-methyl-D-aspartic acid receptor
Organometallic Compounds
Protein Kinase C
Protein kinase C
Pyrones
Receptors, Metabotropic Glutamate
Receptors, N-Methyl-D-Aspartate
Synaptic plasticity impairment

Anmerkungen:

Date Completed 04.01.2021

Date Revised 04.01.2021

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.etap.2020.103406

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM310205891